Is Delcath Systems, Inc. overvalued or undervalued?
2025-10-21 12:07:43As of 17 October 2025, the valuation grade for Delcath Systems, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its significant valuation ratios, including a Price to Book Value of 7.11, an EV to Capital Employed of 23.86, and an EV to Sales of 9.50. In comparison to its peers, Delcath's P/E ratio of 68.06 stands in stark contrast to iCAD, Inc. at -19.65 and Eargo, Inc. at -0.61, highlighting its relative overvaluation within the industry. While specific return data is not available, the absence of positive returns in the context of the S&P 500 further reinforces the notion that Delcath Systems, Inc. is not only overvalued but may also be struggling to deliver shareholder value in the current market environment....
Read MoreIs Delcath Systems, Inc. overvalued or undervalued?
2025-10-20 12:25:05As of 17 October 2025, the valuation grade for Delcath Systems, Inc. has moved from fair to expensive, indicating a shift towards overvaluation. The company is considered overvalued based on its high Price to Book Value of 7.11 and an EV to Sales ratio of 9.50, both of which significantly exceed typical industry benchmarks. Additionally, the EV to Capital Employed ratio stands at 23.86, further supporting the notion of overvaluation relative to its peers. In comparison to its peers, Delcath Systems has a P/E ratio of 68.06, which is considerably higher than iCAD, Inc. at -19.65 and Eargo, Inc. at -0.61, both of which are classified as risky. This stark contrast highlights the potential overvaluation of Delcath Systems in the current market. Although return data is not available, the company's recent price movements suggest volatility, reinforcing the concerns regarding its valuation....
Read MoreIs Delcath Systems, Inc. overvalued or undervalued?
2025-10-19 12:02:42As of 17 October 2025, the valuation grade for Delcath Systems, Inc. moved from fair to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its significant P/E ratio of 68.06, a price-to-book value of 7.11, and an EV to sales ratio of 9.50, which are all considerably higher than typical industry benchmarks. In comparison to its peers, Delcath's valuation metrics stand out unfavorably; for instance, iCAD, Inc. shows a P/E ratio of -19.65, while Eargo, Inc. has a P/E of -0.61, both indicating lower valuations in the same industry. The recent stock performance comparison with the S&P 500 is not available, but the high valuation ratios suggest that Delcath Systems may not be positioned favorably in the current market environment....
Read MoreIs Delcath Systems, Inc. technically bullish or bearish?
2025-09-20 19:44:53As of 12 August 2025, the technical trend has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven primarily by the weekly MACD and KST indicators, both of which are bearish. The daily moving averages also reflect a mildly bearish sentiment. The Bollinger Bands indicate a mildly bearish trend on the weekly timeframe, while the monthly view shows a bullish signal. Overall, the mixed signals across different timeframes suggest caution. There is no available multi-period return data to compare the stock's performance against the S&P 500....
Read MoreIs Delcath Systems, Inc. overvalued or undervalued?
2025-09-20 18:19:56As of 6 August 2025, the valuation grade for Delcath Systems, Inc. has moved from risky to expensive, indicating a shift towards overvaluation. The company appears overvalued based on its high Price to Book Value of 7.11 and an EV to Sales ratio of 9.50, which significantly exceeds typical industry benchmarks. Additionally, the EV to Capital Employed ratio stands at 23.86, suggesting that the market is pricing the company at a premium relative to its capital efficiency. In comparison to its peers, Delcath's P/E ratio of 68.06 is markedly higher than iCAD, Inc. at -19.65 and Eargo, Inc. at -0.61, both of which are also classified as risky. This further reinforces the notion that Delcath is overvalued within its industry context. While specific return data is not available, the lack of positive returns relative to the S&P 500 may also suggest that the stock is not performing well, aligning with its expensive...
Read More





